» Articles » PMID: 36584068

Attitudes Toward COVID-19 Vaccination During the State of Emergency in Osaka, Japan

Overview
Journal PLoS One
Date 2022 Dec 30
PMID 36584068
Authors
Affiliations
Soon will be listed here.
Abstract

Background: COVID-19 vaccination for general population started on April 12, 2021, in Osaka, Japan. We investigated public attitudes toward vaccination and associated factors of vaccine hesitancy during the third state of emergency.

Methods: An internet-based, self-reported, cross-sectional survey was conducted in June 2021, using the smartphone health app for residents of Osaka aged ≥18 years. Respondents were asked about their attitudes toward COVID-19 vaccine. Responses "Don't want to receive vaccines" or "Don't know" were defined as vaccine hesitancy (vs. "Received [1st dose]", "Received [2nd dose]", or "Want to receive vaccines"). Multivariable Poisson regression analysis was conducted to examine the associations between hesitancy and population characteristics.

Results: 23,214 individuals (8,482 men & 14,732 women) were included in the analysis. Proportions that answered "Received (1st dose)", "Received (2nd dose)", "Want to receive vaccines", "Don't want to receive vaccines", "Don't know", and "Don't want to answer" were 14.6%, 3.8%, 70.6%, 4.3%, 6.1%, and 0.5% among men; and 11.3%, 6.0%, 64.9%, 6.2%, 11.0%, and 0.6% among women. Factors associated with vaccine hesitancy included being a woman (aPR = 1.33; 95%CI = 1.23-1.44), age 18-39 (aPR = 7.00; 95%CI = 6.01-8.17) and 40-64 years (aPR = 4.25; 95%CI = 3.71-4.88 vs. 65+ years), living alone (aPR = 1.19; 95%CI = 1.08-1.30 vs. living with 3+ members), non-full-time employment and unemployment (aPRs ranged 1.12 to 1.49 vs. full-time employment), cardiovascular diseases/hypertension (aPR = 0.72; 95%CI = 0.65-0.81), and pregnancy (women of reproductive age only) (aPR = 1.35; 95%CI = 1.03-1.76).

Conclusions: Most respondents expressed favorable attitudes toward COVID-19 vaccination while hesitancy was disproportionately high in certain populations. Efforts are needed to ensure accessible vaccine information resources and healthcare services.

Citing Articles

Understanding COVID-19 Vaccine Hesitancy among the General Population in Japan from Public Health Ethical Perspectives: Findings from a Narrative Review.

Kuroda M, Ahmed M, Kuroda K, Lane S Asian Bioeth Rev. 2025; 17(1):141-165.

PMID: 39896082 PMC: 11785853. DOI: 10.1007/s41649-024-00310-8.

References
1.
Dror A, Eisenbach N, Taiber S, Morozov N, Mizrachi M, Zigron A . Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020; 35(8):775-779. PMC: 8851308. DOI: 10.1007/s10654-020-00671-y. View

2.
Hayakawa S, Komine-Aizawa S, Takada K, Kimura T, Yamada H . Anti-SARS-CoV-2 vaccination strategy for pregnant women in Japan. J Obstet Gynaecol Res. 2021; 47(6):1958-1964. PMC: 8251375. DOI: 10.1111/jog.14748. View

3.
Robinson E, Jones A, Lesser I, Daly M . International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. Vaccine. 2021; 39(15):2024-2034. PMC: 7867398. DOI: 10.1016/j.vaccine.2021.02.005. View

4.
MacDonald N . Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015; 33(34):4161-4. DOI: 10.1016/j.vaccine.2015.04.036. View

5.
Iboi E, Ngonghala C, Gumel A . Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.?. Infect Dis Model. 2020; 5:510-524. PMC: 7409819. DOI: 10.1016/j.idm.2020.07.006. View